{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:11:01Z","timestamp":1790914261068,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2017R1A2B4012436"],"award-info":[{"award-number":["NRF-2017R1A2B4012436"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2017R1D1A1B03032449"],"award-info":[{"award-number":["NRF-2017R1D1A1B03032449"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.prp.2019.152434","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T18:43:02Z","timestamp":1557254582000},"page":"152434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["CCNE1 amplification is associated with liver metastasis in gastric carcinoma"],"prefix":"10.1016","volume":"215","author":[{"given":"Binnari","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong Chan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You Jeong","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Yun","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee-Taek","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Ki","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeeyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Mee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2019.152434_bib0005","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/sj.onc.1208613","article-title":"Cyclin E in normal and neoplastic cell cycles","volume":"24","author":"Hwang","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2019.152434_bib0010","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1158\/1078-0432.CCR-16-0620","article-title":"Selective targeting of cyclin E1-Amplified high-grade serous ovarian Cancer by cyclin-dependent kinase 2 and AKT inhibition","volume":"23","author":"Au-Yeung","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2019.152434_bib0015","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3892\/ijo.2015.3268","article-title":"CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas","volume":"48","author":"Nakayama","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.prp.2019.152434_bib0020","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.7150\/jca.24179","article-title":"Prognostic values of CCNE1 amplification and overexpression in Cancer patients: a systematic review and meta-analysis","volume":"9","author":"Zhao","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2019.152434_bib0025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Bass","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.prp.2019.152434_bib0030","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm.3850","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2019.152434_bib0035","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gutjnl-2011-301839","article-title":"A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets","volume":"61","author":"Deng","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.prp.2019.152434_bib0040","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1172\/JCI75200","article-title":"Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma","volume":"124","author":"Kim","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2019.152434_bib0045","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/annonc\/mdy034","article-title":"Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients","volume":"29","author":"Kim","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2019.152434_bib0050","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/modpathol.3800593","article-title":"Comprehensive analysis of 19q12 amplicon in human gastric cancers","volume":"19","author":"Leung","year":"2006","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2019.152434_bib0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/bjc.2016.198","article-title":"Dual CCNE1\/PIK3CA targeting is synergistic in CCNE1-amplified\/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo","volume":"115","author":"Cocco","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2019.152434_bib0060","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1073\/pnas.1014835108","article-title":"Cyclin E amplification\/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients","volume":"108","author":"Scaltriti","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.prp.2019.152434_bib0065","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1002\/ijc.24699","article-title":"Identification of novel hub genes associated with liver metastasis of gastric cancer","volume":"125","author":"Chang","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2019.152434_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmoldx.2019.02.007","article-title":"Tumor heterogeneity Index to detect HER2 amplification by next-generation sequencing: a direct comparison study with immunohistochemistry","author":"Choi","year":"2019","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.prp.2019.152434_bib0075","doi-asserted-by":"crossref","first-page":"90948","DOI":"10.18632\/oncotarget.18770","article-title":"PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2019.152434_bib0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ccr.2007.08.030","article-title":"A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer","volume":"12","author":"Berns","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2019.152434_bib0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","article-title":"The c-Myc target gene network","volume":"16","author":"Dang","year":"2006","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.prp.2019.152434_bib0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41392-018-0008-7","article-title":"Targeting oncogenic Myc as a strategy for cancer treatment","volume":"3","author":"Chen","year":"2018","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.prp.2019.152434_bib0095","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.prp.2019.152434_bib0100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrd4504","article-title":"The history and future of targeting cyclin-dependent kinases in cancer therapy, nature reviews","volume":"14","author":"Asghar","year":"2015","journal-title":"Drug Discov."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819302511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819302511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:37:41Z","timestamp":1759732661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033819302511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0344033819302511"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2019.152434","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CCNE1 amplification is associated with liver metastasis in gastric carcinoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2019.152434","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"152434"}}